• Abbott reached an agreement with the US Department of Justice to resolve claims tied to its 2022 infant formula recall.
• Settlement set at USD 385 million; agreement states it does not include any finding of fault or liability.
• The US government has closed its criminal investigation related to the matter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609141152PR_NEWS_USPR_____CG46660) on September 14, 2026, and is solely responsible for the information contained therein.